Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Share-based Compensation (IS): 2009-2024

Historic Share-based Compensation (IS) for RedHill Biopharma (RDHL) over the last 11 years, with Dec 2024 value amounting to $665,000.

  • RedHill Biopharma's Share-based Compensation (IS) changed negligibly% to $1,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $8.3 million, marking a year-over-year decrease of 9.81%. This contributed to the annual value of $665,000 for FY2024, which is 59.62% down from last year.
  • RedHill Biopharma's Share-based Compensation (IS) amounted to $665,000 in FY2024, which was down 59.62% from $1.6 million recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Share-based Compensation (IS) registered a high of $5.7 million during FY2022, and its lowest value of $665,000 during FY2024.
  • Over the past 3 years, RedHill Biopharma's median Share-based Compensation (IS) value was $1.6 million (recorded in 2023), while the average stood at $2.7 million.
  • Data for RedHill Biopharma's Share-based Compensation (IS) shows a maximum YoY crashed of 70.98% (in 2023) over the last 5 years.
  • RedHill Biopharma's Share-based Compensation (IS) (Yearly) stood at $5.7 million in 2022, then tumbled by 70.98% to $1.6 million in 2023, then tumbled by 59.62% to $665,000 in 2024.